SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-349704
Filing Date
2011-12-22
Accepted
2011-12-22 08:10:49
Documents
6
Period of Report
2011-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d272774d8k.htm 8-K 22630
2 FORM OF WARRANTS TO PURCHASE SHARES OF COMMON STOCK d272774dex41.htm EX-4.1 87763
3 FORM OF SUBSCRIPTION AGREEMENT d272774dex101.htm EX-10.1 180095
4 FORM OF REGISTRATION RIGHTS AGREEMENT d272774dex102.htm EX-10.2 143269
5 PRESS RELEASE d272774dex991.htm EX-99.1 7605
6 GRAPHIC g272774g08s28.jpg GRAPHIC 3443
  Complete submission text file 0001193125-11-349704.txt   447661
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 111275887
SIC: 2835 In Vitro & In Vivo Diagnostic Substances